USD 15.53
(-7.39%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -148.01 Million USD | 1.08% |
2022 | -149.63 Million USD | 29.73% |
2021 | -212.95 Million USD | -444.3% |
2020 | -39.12 Million USD | 34.0% |
2019 | -59.27 Million USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q3 | -26.41 Million USD | -10.01% |
2024 Q1 | -46.52 Million USD | 1.46% |
2024 Q2 | -24.01 Million USD | 48.39% |
2023 Q3 | -35.04 Million USD | -23.07% |
2023 FY | -148.01 Million USD | 1.08% |
2023 Q4 | -47.2 Million USD | -34.7% |
2023 Q2 | -28.47 Million USD | 23.8% |
2023 Q1 | -37.37 Million USD | 34.43% |
2022 Q1 | -45.15 Million USD | 5.59% |
2022 FY | -149.63 Million USD | 29.73% |
2022 Q4 | -56.99 Million USD | -41.61% |
2022 Q3 | -40.24 Million USD | -143.74% |
2022 Q2 | -16.51 Million USD | 63.44% |
2021 FY | -212.95 Million USD | -444.3% |
2021 Q4 | -47.83 Million USD | -4.4% |
2021 Q3 | -45.81 Million USD | -2.35% |
2021 Q2 | -44.76 Million USD | 21.3% |
2021 Q1 | -56.87 Million USD | -77.37% |
2020 Q3 | 10.84 Million USD | 29.66% |
2020 Q2 | 8.36 Million USD | 183.05% |
2020 Q4 | -32.06 Million USD | -395.64% |
2020 Q1 | -10.07 Million USD | 0.0% |
2020 FY | -39.12 Million USD | 34.0% |
2019 FY | -59.27 Million USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Clover Health Investments, Corp. | -213.36 Million USD | 30.626% |
NewGenIvf Group Limited | -690.85 Thousand USD | -21325.315% |